The concept is to take tissues from patients, expand the fibroblasts and reinject them for cosmetic applications. With R&D support from Anhui Medical University and CAS, the center will establish facilities for 10.000 autologous fibroblast regenerations per year, with a future capacity of 30.000 cases a year, to be the largest center in Asia for this method.

China Industrial Biotechnology Network, April 25, 2013